Inventor · disambiguated record
Martin Ungerer
Also filed as: UNGERER MARTIN
6 granted patents·11 pending applications·37 citations·filing 2001–2022
74Inventor score
Top patents by PatentIndex Score
17 records- 0185US7169612B2Use of EDG2 receptor in an animal model of heart failureSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Jan 30, 2007·34 cites·7 claims
- 0255US7514543B2Polynucleotides encoding immunoadhesins comprising a glycoprotein VI domainTRIGEN GMBH·Filed 2003·Granted Apr 7, 2009·3 cites·11 claims
- 0354US12060409B2Short cyclic peptides for the treatment of Graves' diseaseADVANCECOR GMBH·Filed 2019·Granted Aug 13, 2024·0 cites·12 claims
- 0451US2025026788A1Peptides for the treatment of chronically active autoimmune inflammationADVANCECOR GMBH·Filed 2022·Application pending·0 cites
- 0545US7531178B2Immunoadhesin comprising a glycoprotein VI domainTRIGEN GMBH·Filed 2004·Granted May 12, 2009·0 cites·7 claims
- 0642US11459375B2Cyclic peptides for the treatment of Graves' diseaseADVANCECOR GMBH·Filed 2018·Granted Oct 4, 2022·0 cites·7 claims
- 0741US2004029775A1Methods and compounds for influencing beta3-integrin-dependent intracellular processesFiled 2001·Application pending·0 cites
- 0838US2005112701A1Test system for the identification of APJ receptor ligandsAVENTIS PHARMA GMBH·Filed 2004·Application pending·0 cites
- 0936US2005086710A1Method for generating recombinant human platelets for identifying therapeutic target proteinsFiled 2003·Application pending·0 cites
- 1035US2003049258A1Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscleFiled 2001·Application pending·0 cites
- 1133US2006194819A1Activation specific inhibitors of nf-kb and method of treating inflammatory processes in cardio-vascular diseasesPROCORDE GMBH·Filed 2004·Application pending·0 cites
- 1233US2009130021A1Methods, products and uses involving platelets and/or the vasculatureMUNCH GOTZ·Filed 2005·Application pending·0 cites
- 1333US2014273015A1BINDING COMPOUNDS TO HUMAN Beta 1-ADRENORECEPTOR (Beta 1-AR) AND THEIR USE IN MEASUREMENT OF AUTO-ANTI- Beta 1-AR ANTIBODIESHOLTHOFF HANS-PETER·Filed 2012·Application pending·0 cites
- 1432US2005233405A1Inhibitors of caspase-3-mediated cleavage of essential ventricular myosin light chainPROCORDE GMBH·Filed 2003·Application pending·0 cites
- 1530US11072643B2Fusion proteinADVANCECOR GMBH·Filed 2018·Granted Jul 27, 2021·0 cites·12 claims
- 1630US2003130216A1Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease(cad) for treating cardiac diseaseFiled 2001·Application pending·0 cites
- 1729US2004241166A1Use of inhibitors of ikk-beta and method for discovery of said inhibitorsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Ungerer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →